Concurrent Imatinib and Radiation Therapy for Unresectable and Symptomatic Desmoid Tumors

Table 2

Selected previous studies of desmoid tumors treated with imatinib or radiation therapy alone.

Manuscript	Toxicity	Local control
Imatinib alone
Heinrich et al. 2006 [8]	≥50% grade 3	36.8% at 1 year
Chugh et al. 2010 [7]	≥9.8% grade 3/4	66% at 1 year
Penel et al. 2011 [9]	45% grade 3	67% at 1 year
Radiation alone
Nuyttens et al. 2000 [10]	22.8% total	78% at 6 years
Guadagnolo et al. 2008 [11]	10.5% moderate, 4.3% severe	68% at 10 years
Keus et al. 2013 [19]	4.5% grade 3	81.5% at 3 years